Page 1 | Search Results | Blood | American Society of Hematology

1-10 of 10

Sort by

Sort Order Select

Journal Articles

Molecular Mechanisms Regulating Migration and Adhesion in Response to the Chemokine SDF-1 in Multiple Myeloma (MM).

Irene Ghobrial, MD, Ujjal Singha, PhD, Yazan Alsayed, MD, Alissa Huston, MD, Lanie Francis, MD, Ganwei Lu, MD, Judy Anderson, Suzanne Lentzsch, MD, G. David Roodman, MD, PhD

Blood (2005) 106 (11): 2491.

https://doi.org/10.1182/blood.V106.11.2491.2491

Published: 2005

Journal Articles

The Role of the CXCR4 Inhibitor AMD3100 in Multiple Myeloma (MM).

Irene M. Ghobrial, MD, Mona Melhem, Ujjal Singha, PhD, Diane George, PhD, Michael Timm, Lanie Francis, MD, Yazan Alsayed, MD, Alissa Huston, MD, G. D. Roodman, MD, PhD

Blood (2005) 106 (11): 2492.

https://doi.org/10.1182/blood.V106.11.2492.2492

Published: 2005

Journal Articles

Differential Response to Proteosome Inhibition in EBV Positive and Negative Lymphoma Cell Lines: Clinical Implications in Post Transplant Lymphoproliferative Disorders (PTLD).

Yazan Alsayed, MD, Ujjal Singha, PhD, Lanie Francis, MD, Alissa Huston, MD, Ganwei Lu, MD, Judy Anderson, Suzanne Lentzsch, MD, G. David Roodman, MD, PhD, Irene Ghobrial, MD

Blood (2005) 106 (11): 2413.

https://doi.org/10.1182/blood.V106.11.2413.2413

Published: 2005

Journal Articles

Combination of the mTOR Inhibitor Rapamycin with the HSP90 Inhibitor 17-AAG Has Synergistic Activity in EBV Positive Post Transplant Lymphoproliferative Disorders (PTLD).

Yazan Alsayed, MD, Ujjal Singha, PhD, Lanie Francis, MD, Alissa Huston, MD, Ganwei Lu, MD, Judy Anderson, Suzanne Lentzsch, MD, G. David Roodman, MD, PhD, Irene M. Ghobrial, MD

Blood (2005) 106 (11): 2414.

https://doi.org/10.1182/blood.V106.11.2414.2414

Published: 2005

Journal Articles

The Effect of Rapamycin, 17-AAG and the Combination on the Bone Marrow Microenvironment in Multiple Myeloma (MM).

Lanie Francis, MD, Judy Anderson, BS, Michael Timm, BS, Noriyoshi Kurihara, PhD, Ujjal Singha, PhD, Yazan Alsayed, MD, Alissa Huston, MD, Suzanne Lentzsch, MD, PhD, G. David Roodman, MD, PhD, Irene M. Ghobrial, MD

Blood (2005) 106 (11): 3476.

https://doi.org/10.1182/blood.V106.11.3476.3476

Published: 2005

Journal Articles

Proteomic Analysis of Post Transplant Lymphoproliferative Disorders (PTLD) Using Nanoscale Protein Microarray Techniques.

Yazan Alsayed, MD, Alexey Leontovich, PhD, Michael Timm, BS, Mona Melhem, MD, Michael Nalesnik, MD, Diane George, BS, Ujjal Singha, PhD, Alissa Huston, MD, Lanie Francis, MD, Suzanne Lentzsch, MD, G. David Roodman, MD, PhD, Ronald Herberman, MD, Irene M. Ghobrial, MD

Blood (2005) 106 (11): 286.

https://doi.org/10.1182/blood.V106.11.286.286

Published: 2005

Journal Articles

Proteomic Analysis Identifies Differences in Multiple Myeloma (MM) Cells Sensitive and Resistant to AKT Inhibition.

Alissa Huston, MD, Alexey Leontovich, MD, Michael Timm, MD, Yazan Alsayed, MD, Ujjal Singha, PhD, Lanie Francis, MD, Ganwei Lu, PhD, Judy Anderson, Suzanne Lentzsch, MD, Irene Ghobrial, MD

Blood (2005) 106 (11): 3402.

https://doi.org/10.1182/blood.V106.11.3402.3402

Published: 2005

Journal Articles

The Role of the AKT Inhibitor Perifosine in Migration and Adhesion in Multiple Myeloma (MM).

Alissa Huston, MD, Ujjal Singha, PhD, Yazan Alsayed, MD, Lanie Francis, MD, Ganwei Lu, MD, Judy Anderson, Suzanne Lentzsch, MD, G. David Roodman, MD, PhD, Irene M. Ghobrial, MD

Blood (2005) 106 (11): 2509.

https://doi.org/10.1182/blood.V106.11.2509.2509

Published: 2005

Journal Articles

Proteomic Analysis of Waldenstrom Macroglobulinemia (WM) Using Nanoscale Protein Micorarray Techniques.

Yazan Alsayed, MD, Michael Timm, MD, Alexey Leontovich, MD, Daniel Santos, MD, Allen Ho, MD, Ujjal Singha, PhD, Lanie Francis, MD, Alissa Huston, MD, Ganwei Lu, MD, Suzanne Lentzsch, MD, G. David Roodman, MD, PhD, Leleu Xavier, MD, Steven Treon, MD, PhD, Irene M. Ghobrial, MD

Blood (2005) 106 (11): 504.

https://doi.org/10.1182/blood.V106.11.504.504

Published: 2005

Journal Articles

Role of the Chemokine Receptor CXCR4 in Waldenstrom Macroglobulinemia.

Irene M. Ghobrial, MD, Mona Melhem, MD, Ujjal Singha, PhD, Diane George, Michael Timm, MD, Lanie Francis, MD, Yazan Alsayed, MD, Alissa Huston, MD, G. David Roodman, MD, PhD, Philip Greipp, MD, Morie Gertz, MD, Thomas Witzig, MD

Blood (2005) 106 (11): 993.

https://doi.org/10.1182/blood.V106.11.993.993

Published: 2005

NARROW

Molecular Mechanisms Regulating Migration and Adhesion in Response to the Chemokine SDF-1 in Multiple Myeloma (MM).

The Role of the CXCR4 Inhibitor AMD3100 in Multiple Myeloma (MM).

Differential Response to Proteosome Inhibition in EBV Positive and Negative Lymphoma Cell Lines: Clinical Implications in Post Transplant Lymphoproliferative Disorders (PTLD).

Combination of the mTOR Inhibitor Rapamycin with the HSP90 Inhibitor 17-AAG Has Synergistic Activity in EBV Positive Post Transplant Lymphoproliferative Disorders (PTLD).

The Effect of Rapamycin, 17-AAG and the Combination on the Bone Marrow Microenvironment in Multiple Myeloma (MM).

Proteomic Analysis of Post Transplant Lymphoproliferative Disorders (PTLD) Using Nanoscale Protein Microarray Techniques.

Proteomic Analysis Identifies Differences in Multiple Myeloma (MM) Cells Sensitive and Resistant to AKT Inhibition.

The Role of the AKT Inhibitor Perifosine in Migration and Adhesion in Multiple Myeloma (MM).

Proteomic Analysis of Waldenstrom Macroglobulinemia (WM) Using Nanoscale Protein Micorarray Techniques.

Role of the Chemokine Receptor CXCR4 in Waldenstrom Macroglobulinemia.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only